157 related articles for article (PubMed ID: 7473544)
1. Hydroxylated aromatic inhibitors of HIV-1 integrase.
Burke TR; Fesen MR; Mazumder A; Wang J; Carothers AM; Grunberger D; Driscoll J; Kohn K; Pommier Y
J Med Chem; 1995 Oct; 38(21):4171-8. PubMed ID: 7473544
[TBL] [Abstract][Full Text] [Related]
2. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.
Mazumder A; Gazit A; Levitzki A; Nicklaus M; Yung J; Kohlhagen G; Pommier Y
Biochemistry; 1995 Nov; 34(46):15111-22. PubMed ID: 7578125
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds.
Fesen MR; Pommier Y; Leteurtre F; Hiroguchi S; Yung J; Kohn KW
Biochem Pharmacol; 1994 Aug; 48(3):595-608. PubMed ID: 7520698
[TBL] [Abstract][Full Text] [Related]
5. Arylamide inhibitors of HIV-1 integrase.
Zhao H; Neamati N; Mazumder A; Sunder S; Pommier Y; Burke TR
J Med Chem; 1997 Apr; 40(8):1186-94. PubMed ID: 9111292
[TBL] [Abstract][Full Text] [Related]
6. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
[TBL] [Abstract][Full Text] [Related]
7. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase.
Eich E; Pertz H; Kaloga M; Schulz J; Fesen MR; Mazumder A; Pommier Y
J Med Chem; 1996 Jan; 39(1):86-95. PubMed ID: 8568830
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type-1 integrase by curcumin.
Mazumder A; Raghavan K; Weinstein J; Kohn KW; Pommier Y
Biochem Pharmacol; 1995 Apr; 49(8):1165-70. PubMed ID: 7748198
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
Zhang L; Zhang H; Zheng X; Zhao Y; Chen S; Chen Y; Zhang R; Li Q; Hu X
ChemMedChem; 2014 Apr; 9(4):706-9. PubMed ID: 24436249
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid phenethyl ester (CAPE) analogues: potent nitric oxide inhibitors from the Netherlands propolis.
Nagaoka T; Banskota AH; Tezuka Y; Midorikawa K; Matsushige K; Kadota S
Biol Pharm Bull; 2003 Apr; 26(4):487-91. PubMed ID: 12673030
[TBL] [Abstract][Full Text] [Related]
13. Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integrase.
Zhang X; Neamati N; Lee YK; Orr A; Brown RD; Whitaker N; Pommier Y; Burke TR
Bioorg Med Chem; 2001 Jul; 9(7):1649-57. PubMed ID: 11425564
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation.
Kim H; Kim W; Yum S; Hong S; Oh JE; Lee JW; Kwak MK; Park EJ; Na DH; Jung Y
Free Radic Biol Med; 2013 Dec; 65():552-562. PubMed ID: 23892357
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of human immunodeficiency virus integrase.
Fesen MR; Kohn KW; Leteurtre F; Pommier Y
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2399-403. PubMed ID: 8460151
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex.
Mazumder A; Gupta M; Perrin DM; Sigman DS; Rabinovitz M; Pommier Y
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):115-25. PubMed ID: 7734185
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching.
Nicklaus MC; Neamati N; Hong H; Mazumder A; Sunder S; Chen J; Milne GW; Pommier Y
J Med Chem; 1997 Mar; 40(6):920-9. PubMed ID: 9083480
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase.
Robinson WE; Reinecke MG; Abdel-Malek S; Jia Q; Chow SA
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6326-31. PubMed ID: 8692814
[TBL] [Abstract][Full Text] [Related]
19. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo.
Ho CC; Lin SS; Chou MY; Chen FL; Hu CC; Chen CS; Lu GY; Yang CC
J Antimicrob Chemother; 2005 Aug; 56(2):372-9. PubMed ID: 16002419
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.
Natarajan K; Singh S; Burke TR; Grunberger D; Aggarwal BB
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9090-5. PubMed ID: 8799159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
